Share

May 17, 2016; 86 (20) Resident and Fellow Section

Clinical Reasoning: Heart to swallow

David J. van Westerloo, Daniela Q. Barge-Schaapveld, Hennie Bikker, Martijn S. van Noorden, Martijn R. Tannemaat
First published May 16, 2016, DOI: https://doi.org/10.1212/WNL.0000000000002681
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
945

Share

Article Information

vol. 86 no. 20 e210-e214
DOI: 
https://doi.org/10.1212/WNL.0000000000002681
PubMed: 
27185901
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published May 16, 2016.
Copyright & Usage: 
© 2016 American Academy of Neurology

Author Disclosures

    1. David J. van Westerloo, MD, PhD,
    2. Daniela Q. Barge-Schaapveld, MD, PhD,
    3. Hennie Bikker, PhD,
    4. Martijn S. van Noorden, MD, PhD and
    5. Martijn R. Tannemaat, MD, PhD
  1. David J. van Westerloo, MD, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Netherlands Journal of Critical Care Medicine, associate editor, 2015.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Daniela Q. Barge-Schaapveld, MD, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Hennie Bikker, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Martijn S. van Noorden, MD, PhD and
    5. Scientific Advisory Boards:

    1. Scientific advisory board Dutch GHB Monitor. Non-commercial; no financial compensation.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Martijn R. Tannemaat, MD, PhD
    6. Scientific Advisory Boards:

    1. Araim Pharmaceuticals

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. Araim Pharmaceuticals, 2014

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Intensive Care (D.J.v.W.), Cardiogenetics (D.Q.B.-S.), Psychiatry (M.S.v.N.), and Neurology (M.R.T.), Leiden University Medical Centre, Leiden; and Department of Clinical Genetics (H.B.), Academic Medical Centre, Amsterdam, the Netherlands.
  1. Correspondence to Dr. van Westerloo: djvanwesterloo{at}lumc.nl
View Full Text

Article usage

Article usage: May 2016 to May 2023

AbstractFullPdfSource
May 2016692549284Highwire
Jun 20161185967Highwire
Jul 2016493431Highwire
Aug 2016311815Highwire
Sep 20162478Highwire
Oct 2016329514Highwire
Nov 2016258416Highwire
Dec 2016301911Highwire
Jan 2017233110Highwire
Feb 201715513Highwire
Mar 20171245Highwire
Apr 20172196Highwire
May 201718811Highwire
Jun 20171285Highwire
Jul 2017883Highwire
Aug 201711173Highwire
Sep 201711343Highwire
Oct 20179113Highwire
Nov 20171596Highwire
Dec 2017185Highwire
Jan 20182181Highwire
Feb 2018182Highwire
Mar 201821511Highwire
Apr 20182129Highwire
May 20184168Highwire
Jun 20180109Highwire
Jul 20181129Highwire
Aug 20180171Highwire
Sep 2018185Highwire
Oct 2018185Highwire
Nov 20182196Highwire
Dec 20180144Highwire
Jan 20192155Highwire
Feb 20192239Highwire
Mar 20192228Highwire
Apr 2019167Highwire
May 20190203Highwire
Jun 2019275Highwire
Jul 20190145Highwire
Aug 20190116Highwire
Sep 20190124Highwire
Oct 20193185Highwire
Nov 20190299Highwire
Dec 20193278Highwire
Jan 20200133Highwire
Feb 2020072Highwire
Mar 20200112Highwire
Apr 2020199Highwire
May 20201256Highwire
Jun 2020397Highwire
Jul 2020063Highwire
Aug 2020165Highwire
Sep 20205168Highwire
Oct 20200155Highwire
Nov 202031311Highwire
Dec 20202153Highwire
Jan 20212749Highwire
Feb 20211166Highwire
Mar 202133412Highwire
Apr 20213442Highwire
May 202112310Highwire
Jun 20214172Highwire
Jul 20212248Highwire
Aug 20215196Highwire
Sep 20213269Highwire
Oct 202111417Highwire
Nov 202112116Highwire
Dec 20211234Highwire
Jan 20221123Highwire
Feb 20223197Highwire
Mar 20221288Highwire
Apr 20220148Highwire
May 202222012Highwire
Jun 20221119Highwire
Jul 2022083Highwire
Aug 2022253Highwire
Sep 202201111Highwire
Oct 20220217Highwire
Nov 20222105Highwire
Dec 20220168Highwire
Jan 202301413Highwire
Feb 20231207Highwire
Mar 2023175Highwire
Apr 20231118Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles